Multiple Myeloma: Nuances of Minimal Residual Disease Diagnosis and Monitoring with the Use of Multicolor Flow Cytometry
Irina Galtseva(National Research Center for Preventive Medicine), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Yulia Davydova(National Research Center for Preventive Medicine), Е. Н. Паровичникова(National Research Center for Hematology Russian Academy of Medical Sciences), К. А. Никифорова, Н. М. Капранов(National Research Center for Preventive Medicine), M. V. Solovev(Ministry of Health of the Russian Federation)
Cited by 1
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59